Healthcare provider profile · identity verified

Michael A Musho, M.D.

Internal Medicine · ROCKLEDGE, PA · NPI 1548255912

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	624	207
Lisinopril	Lisinopril	429	135
Amlodipine Besylate	Amlodipine Besylate	425	134
Simvastatin	Simvastatin	343	113
Levothyroxine Sodium	Levothyroxine Sodium	323	100
Omeprazole	Omeprazole	300	92
Metoprolol Succinate	Metoprolol Succinate	185	62
Losartan Potassium	Losartan Potassium	178	58
Metformin Hcl Er	Metformin Hcl	165	50
Hydrochlorothiazide	Hydrochlorothiazide	164	60
Rosuvastatin Calcium	Rosuvastatin Calcium	155	54
Pantoprazole Sodium	Pantoprazole Sodium	151	43
Metformin Hcl	Metformin Hcl	144	45
Alprazolam	Alprazolam	138	31
Furosemide	Furosemide	120	48
Fluticasone Propionate	Fluticasone Propionate	119	50
Tamsulosin Hcl	Tamsulosin Hcl	118	37
Atenolol	Atenolol	116	35
Sertraline Hcl	Sertraline Hcl	116	38
Lorazepam	Lorazepam	107	37
Eliquis	Apixaban	104	24
Albuterol Sulfate Hfa	Albuterol Sulfate	102	38
Januvia	Sitagliptin Phosphate	98	22
Clopidogrel	Clopidogrel Bisulfate	97	31
Gabapentin	Gabapentin	92	32
Escitalopram Oxalate	Escitalopram Oxalate	88	29
Montelukast Sodium	Montelukast Sodium	86	24
Metoprolol Tartrate	Metoprolol Tartrate	85	28
Ezetimibe	Ezetimibe	78	26
Famotidine	Famotidine	74	26
Glipizide Er	Glipizide	71	23
Trazodone Hcl	Trazodone Hcl	67	14
Carvedilol	Carvedilol	65	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	63	22
Zolpidem Tartrate	Zolpidem Tartrate	62	22
Diazepam	Diazepam	61	11
Glimepiride	Glimepiride	57	17
Potassium Chloride	Potassium Chloride	55	19
Allopurinol	Allopurinol	54	20
Meloxicam	Meloxicam	52	15
Tramadol Hcl	Tramadol Hcl	52	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	52	19
Finasteride	Finasteride	49	18
Azithromycin	Azithromycin	48	42
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	47	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	15
Lovastatin	Lovastatin	46	14
Valsartan	Valsartan	44	17
Trulicity	Dulaglutide	42	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	41	13
Hydralazine Hcl	Hydralazine Hcl	40	13
Mirtazapine	Mirtazapine	40	14
Pravastatin Sodium	Pravastatin Sodium	38	15
Paroxetine Hcl	Paroxetine Hcl	37	15
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	35	13
Nifedipine Er	Nifedipine	35	11
Carbamazepine	Carbamazepine	34	suppressed
Clonazepam	Clonazepam	33	suppressed
Amoxicillin	Amoxicillin	32	27
Celecoxib	Celecoxib	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	13
Bupropion Xl	Bupropion Hcl	31	suppressed
Gemfibrozil	Gemfibrozil	31	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	29	suppressed
Ondansetron Hcl	Ondansetron Hcl	29	suppressed
Ozempic	Semaglutide	29	suppressed
Alendronate Sodium	Alendronate Sodium	28	suppressed
Colchicine	Colchicine	28	suppressed
Naproxen	Naproxen	28	17
Warfarin Sodium	Warfarin Sodium	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Irbesartan	Irbesartan	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Temazepam	Temazepam	26	suppressed
Ibuprofen	Ibuprofen	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	24	suppressed
Enalapril Maleate	Enalapril Maleate	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Baclofen	Baclofen	23	suppressed
Glipizide	Glipizide	23	suppressed
Jardiance	Empagliflozin	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	19	suppressed
Methotrexate	Methotrexate Sodium	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	suppressed
Topiramate	Topiramate	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Prednisone	Prednisone	17	suppressed
Ramipril	Ramipril	17	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	14
Raloxifene Hcl	Raloxifene Hcl	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Clonidine	Clonidine	15	suppressed
Methylprednisolone	Methylprednisolone	15	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Carbamazepine Er	Carbamazepine	13	suppressed
Duloxetine Hcl	Duloxetine Hcl	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	13	suppressed
Mometasone Furoate	Mometasone Furoate	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	13	suppressed
Sotalol	Sotalol Hcl	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Clonidine Hcl Er	Clonidine Hcl	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Nadolol	Nadolol	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Repaglinide	Repaglinide	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Cephalexin	Cephalexin	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error